Press Releases
Media Coverage 


Events  
 
Scientific
 
Investor




   
Featured News and Events  
 

Upcoming Events:

No upcoming events scheduled. Check back soon

Past Events:

In Business Las Vegas to honor
Dr. Thomas J. Stegmann, MD, PhD

"Health Care Headliners: Saluting Individuals and organizations who do extraordinary things in the health care industry"
Thursday, April 10, 2008, 6:00 - 8:00 PM
Platinum Hotel, Las Vegas, NV

Lecture of Dr. Thomas J. Stegmann, MD, PhD
"Angiogenesis: Perfusion is All That Matters"
Sunday, March 09, 2008, 08:00 PM.
Stuko Convention Center, Tel Aviv, Israel

American Heart Association’s 3rd Annual “Go Red for Women” Luncheon
Four Seasons Hotel, Las Vegas
Thursday, February 27, 2008

Regenerative Medicine Organization 5th Annual Conference
The Venetian Las Vegas
February 17-19, 2008

Department of Biomedical Sciences, Florida State University
Tallahassee, Florida
November 1, 2007
Presentation Title: “Angiogenesis – a New Principle of Treatment for Cardiovascular Disease” by Dr. Thomas Stegmann
Presentation Date: November 1st
 

From left to right: Cristina Russo (MOB graduate student, Co-Pi with Dr. Marcia Fenley and Michael Blaber), Zhe Xu (COM graduate student), Hyesook Yoon (Chemistry & Biochemistry graduate student), Prof. Dr. Thomas Stegmann, Dr. Michael Blaber, Dr. Hugh Nymeyer (professor of Chemistry & Biochemistry and Computational Sciences collaborator), Dr. Jihun Lee (postdoctoral researcher), Liam Longo (undergraduate researcher).


No-Option Heart Patients Celebrate 10 Years of Life


September 2005, Dr. Thomas Stegmann and patients from his German clinical studies in Fulda, come together to celebrate their 10 year anniversary of survival.


See the full Press Release.

 

 

 

 

Use of this site constitutes agreement to our Terms and Conditions
and Privacy Policy. Site Design and Contents © 2008 CardioVascular BioTherapeutics, Inc. All Rights Reserved.

Some content on this site requires the free Adobe Reader.

 

7/1/2008
Dutton Associates Announces Investment Opinion: CardioVascular BioTherapeutics Maintained At Neutral Rating By Dutton Associates


6/10/2008
CVBT Inks Third Clinical Development Agreement


5/22/2008
Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial


4/24/2008
CardioVascular BioTherapeutics, Inc. Funding Wound Healing Trial with R&D Partnership